These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32395850)

  • 1. Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.
    Deacon RM; Mammen K; Holmes J; Dunlop A; Bruno R; Mills L; Graham R; Lintzeris N
    Drug Alcohol Rev; 2020 Jul; 39(5):441-446. PubMed ID: 32395850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
    Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N
    Addiction; 2021 May; 116(5):1245-1255. PubMed ID: 33201546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study.
    Lintzeris N; Monds LA; Rivas G; Leung S; Withall A; Draper B
    Drug Alcohol Rev; 2016 Nov; 35(6):673-677. PubMed ID: 27072851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings.
    Ryan A; Holmes J; Hunt V; Dunlop A; Mammen K; Holland R; Sutton Y; Sindhusake D; Rivas G; Lintzeris N
    Drug Alcohol Rev; 2014 Jan; 33(1):33-42. PubMed ID: 24206571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.
    Deacon RM; Mills L; Bruno R; Mammen K; Dunlop A; Childs S; Shakeshaft A; Holmes J; Lintzeris N
    Addiction; 2023 Dec; 118(12):2457-2465. PubMed ID: 37421220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).
    Lawrinson P; Copeland J; Indig D
    Drug Alcohol Depend; 2005 Oct; 80(1):125-33. PubMed ID: 15869845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.
    Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N
    Drug Alcohol Rev; 2022 Jan; 41(1):106-113. PubMed ID: 34189792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services.
    Lintzeris N; Rivas C; Monds LA; Leung S; Withall A; Draper B
    Drug Alcohol Rev; 2016 Mar; 35(2):223-31. PubMed ID: 26498741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.
    Skelton E; Tzelepis F; Shakeshaft A; Guillaumier A; Dunlop A; McCrabb S; Palazzi K; Bonevski B
    J Subst Abuse Treat; 2017 Jun; 77():101-106. PubMed ID: 28476261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.
    Mills L; Lintzeris N; Bruno R; Montebello M; Dunlop A; Deacon RM; Copeland J; Jefferies M; Rivas C; Mammen K
    Drug Alcohol Rev; 2020 May; 39(4):356-364. PubMed ID: 32129558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of online self-report versions of the Australian Treatment Outcome Profile (ATOP) and Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) among people in residential treatment for substance use problems.
    Carlyle M; Walter ZC; Theroux B; Leung J; Hides L
    Addict Behav; 2023 Sep; 144():107756. PubMed ID: 37257357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ordering clinical realities: Controversy and multiplicity in alcohol and other drug treatment for young adults.
    Hart A
    Int J Drug Policy; 2018 Feb; 52():79-86. PubMed ID: 29272742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Telephone-Based Application of the ABILHAND for Assessment of Manual Ability After Stroke.
    Avelino PR; Menezes KKP; Nascimento LR; Tenório RA; Cândido GN; Christovão IS; Teixeira-Salmela LF
    J Neurol Phys Ther; 2020 Oct; 44(4):256-260. PubMed ID: 32815891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Private practice metropolitan telepsychiatry in larger Australian states during the COVID-19 pandemic: an analysis of the first 2 months of new MBS telehealth item psychiatrist services.
    Looi JC; Allison S; Bastiampillai T; Pring W
    Australas Psychiatry; 2020 Dec; 28(6):644-648. PubMed ID: 32997521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Private practice metropolitan telepsychiatry in smaller Australian jurisdictions during the COVID-19 pandemic: preliminary analysis of the introduction of new Medicare Benefits Schedule items.
    Looi JC; Allison S; Bastiampillai T; Pring W
    Australas Psychiatry; 2020 Dec; 28(6):639-643. PubMed ID: 33016772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of a computer-based psychological treatment in a drug and alcohol clinical service: an observational study.
    Kay-Lambkin FJ; Simpson AL; Bowman J; Childs S
    Addict Sci Clin Pract; 2014 Aug; 9(1):15. PubMed ID: 25106668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol and other drug specialist treatment services and their managers: findings from a national survey.
    Roche A; O'Neill M; Wolinski K
    Aust N Z J Public Health; 2004 Jun; 28(3):252-8. PubMed ID: 15707172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the effectiveness of a healthy lifestyle clinician in addressing the chronic disease risk behaviours of community mental health clients: study protocol for a randomised controlled trial.
    Fehily C; Bartlem K; Wiggers J; Wye P; Clancy R; Castle D; Wutzke S; Rissel C; Wilson A; McCombie P; Murphy F; Bowman J
    Trials; 2017 Jun; 18(1):276. PubMed ID: 28619025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and reliable change in an Australian residential substance use program using the Addiction Severity Index.
    Deane FP; Kelly PJ; Crowe TP; Coulson JC; Lyons GC
    J Addict Dis; 2013; 32(2):194-205. PubMed ID: 23815426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.